Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed L Sorror

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Hematology. American Society of Hematology. Education Program|January 18, 2011
Comorbidities and hematopoietic cell transplantation outcomesMohamed L Sorror
Blood|January 29, 2013
How I assess comorbidities before hematopoietic cell transplantationMohamed L Sorror
Leukemia & Lymphoma|April 3, 2015
Defining vulnerability in allogeneic transplants is more complicated than the two numerical digits of ageMohamed L Sorror
Transplantation and Cellular Therapy|July 30, 2023
Initial steps towards improving quality of care for allogeneic hematopoietic cell transplantation recipients at individual centersMohamed L Sorror
Blood|February 17, 2023
The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigatorsMohamed L Sorror
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 28, 2011
Comorbidities and outcomes: advancing the field comes at a priceMohamed L Sorror
Hematology. American Society of Hematology. Education Program|February 20, 2015
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adultsMohamed L Sorror, Elihu Estey
Blood Advances|June 4, 2026
Implementing CHARM in Transplant PracticeMohamed L Sorror, Andrew S Artz
Mediterranean Journal of Hematology and Infectious Diseases|December 15, 2010
Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantationMohamed L Sorror, Rainer F Storb
Hematology. American Society of Hematology. Education Program|December 9, 2023
What makes a pediatric or young adult patient an appropriate transplant candidate?Monica S Thakar, Mohamed L Sorror
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Hematology. American Society of Hematology. Education Program|January 18, 2011
Comorbidities and hematopoietic cell transplantation outcomesMohamed L Sorror
Blood|January 29, 2013
How I assess comorbidities before hematopoietic cell transplantationMohamed L Sorror
Leukemia & Lymphoma|April 3, 2015
Defining vulnerability in allogeneic transplants is more complicated than the two numerical digits of ageMohamed L Sorror
Transplantation and Cellular Therapy|July 30, 2023
Initial steps towards improving quality of care for allogeneic hematopoietic cell transplantation recipients at individual centersMohamed L Sorror
Blood|February 17, 2023
The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigatorsMohamed L Sorror
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 28, 2011
Comorbidities and outcomes: advancing the field comes at a priceMohamed L Sorror
Hematology. American Society of Hematology. Education Program|February 20, 2015
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adultsMohamed L Sorror, Elihu Estey
Blood Advances|June 4, 2026
Implementing CHARM in Transplant PracticeMohamed L Sorror, Andrew S Artz
Mediterranean Journal of Hematology and Infectious Diseases|December 15, 2010
Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantationMohamed L Sorror, Rainer F Storb
Hematology. American Society of Hematology. Education Program|December 9, 2023
What makes a pediatric or young adult patient an appropriate transplant candidate?Monica S Thakar, Mohamed L Sorror
Pageof 13